CompletedNot Applicable

Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus Stenting

Iran114 participantsStarted 2009-12

Plain-language summary

Cholangitis is the most prevalent infectious complication of ERCP. Stenting of biliary strictures and stenosis is one of important risk factors for post-ERCP cholangitis. Adding antibiotics to contrast media has proposed in some studies for prevention of cholangitis but remains controversial. In this study we compare effect of adding gentamicin versus placebo in preventing cholangitis in patients who undergone endoscopic stenting for non-calculus strictures and stenosis.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with non-calculus biliary obstruction who need palliative treatment Exclusion Criteria: * Fever (\> 37.8 Celsius) * Leukocytosis (WBC \> 10,000 /mm3) * Not candidate for surgical cure of obstruction

What they're measuring

Number of Participants With Cholangitis

Timeframe: 72 hours

Trial details

NCT IDNCT01148693

SponsorTehran University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-12

Results submitted2011-02-18

View on ClinicalTrials.gov More Cholangitis trials